Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay Por Adson Machado Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay Read More »
Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer Por Adson Machado Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer Read More »
Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial Por Kati Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial Read More »
Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Por Kati Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Read More »
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Por Kati A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Read More »
Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Por Kati Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Read More »
Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Por Kati Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Read More »
The impact of radiotherapy on trials of axillary management in early breastcancer Por Kati The impact of radiotherapy on trials of axillary management in early breastcancer Read More »
Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Por Kati Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Read More »
The Role of Axillary Lymph NodeDissection in Breast Cancer PatientsWith Residual Nodal Disease AfterReceiving Neoadjuvant Chemotherapy Por Kati The Role of Axillary Lymph NodeDissection in Breast Cancer PatientsWith Residual Nodal Disease AfterReceiving Neoadjuvant Chemotherapy Read More »
Extending the duration of endocrine treatment for earlybreast cancer: patient-level meta-analysis of 12 randomisedtrials of aromatase inhibitors in 22031 postmenopausalwomen already treated with at least 5 years of endocrinetherapy Por Kati Extending the duration of endocrine treatment for earlybreast cancer: patient-level meta-analysis of 12 randomisedtrials of aromatase inhibitors in 22031 postmenopausalwomen already treated with at least 5 years of endocrinetherapy Read More »
Do regularly scheduled visits result in earlier detection of curablebreast cancer recurrences? Por Kati Do regularly scheduled visits result in earlier detection of curablebreast cancer recurrences? Read More »
